Duke University: Brain Neoplasms trials

The registry lists 31 Brain Neoplasms studies with Duke University as lead sponsor. 3 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 4Phase 2 12Phase 4 1No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and EpilepsyRecruitingNCT07271966Not applicable
• Key Longitudinal Associations With Risk and Glioblastoma OutcomesRecruitingNCT06625684
• Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain TumorsRecruitingNCT05480644
• Seizure Prophylaxis in Patients With Glioma or Brain MetastasisTerminatedNCT03436433Phase 2Results posted
• SIMT Stereotactic Radiosurgery Outcomes StudyCompletedNCT02886572Not applicableResults posted
• Perampanel in Seizure Patients With Primary Glial Brain TumorsCompletedNCT02363933Phase 4Results posted
• Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma PatientsCompletedNCT01738646Phase 2Results posted
• Optimal Planning Target Volume With Stereotactic RadiosurgeryCompletedNCT01017497Not applicableResults posted
• Stereotactic Radiosurgery After Surgery in Treating Patients With Brain MetastasesTerminatedNCT00814463Phase 2Results posted
• Stereotactic Radiosurgery in Treating Patients With Brain MetastasesTerminatedNCT00811655Phase 2Results posted
• Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With BevacizumabTerminatedNCT00636805Phase 2Results posted
• Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and GliosarcomasCompletedNCT00597402Phase 2Results posted
• A Pilot Study of Dronabinol for Adult Patients With Primary GliomasCompletedNCT00314808Phase 1Results posted
• Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaCompletedNCT00301873Phase 2Results posted
• Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)Active, not recruitingNCT05634707Early Phase 1
• SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung CancerWithdrawnNCT04650490Phase 2
• Survivorship Study of Cancer Patients Who Received Cranial Radiation TherapyTerminatedNCT04567251
• Perioperative Evaluation of Cerebellar TumorsActive, not recruitingNCT04463979
• MRI Following Stereotactic Radiosurgery (SRS) for Brain MetastasesActive, not recruitingNCT04246879Not applicable
• Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain CancerCompletedNCT04075370
• Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced CancerTerminatedNCT02580045
• Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral SclerosisCompletedNCT02457715
• Study of Massage Therapy Within a Brain Tumor SettingCompletedNCT00873184Not applicable
• BTC Neuropsychological DatabaseWithdrawnNCT00873132
• Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor PatientsCompletedNCT00629447Not applicable
• Computerized Cognitive Training for Childhood Cancer SurvivorsTerminatedNCT00629395Not applicable
• Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT00362921Phase 2
• Temozolomide in Treating Patients With Brain MetastasesCompletedNCT00005954Phase 2
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain TumorsCompletedNCT00003478Phase 1/2
• Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain TumorsCompletedNCT00003461Phase 1/2
• Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsCompletedNCT00002754Phase 1